In this episode John and Professor Shah open with why insulin alone has structural limitations in type 1 diabetes, work through how GLP-1 therapies act on the body, and then walk the trial evidence from the early exenatide and liraglutide studies to the more recent semaglutide and tirzepatide data
Does IGF-1 LR3 work for fat loss
Extended Machine Lifespan: Regularly replacing filters prevents the motor from overheating due to dust buildup, protecting your investment for years of travel
As a lipid-dependent organ, the brain utilizes lipids not merely for energy but as signaling molecules essential for neurophysiology
Trained immunity: a memory for innate host defense
To account for the pronounced heterogeneity of the preclinical evidence base, specific inclusion criteria for preclinical studies were defined as follows: (1) Model Type: utilization of established in vivo models (e.g., transgenic AD models like APP/PS1 or 3xTg-AD, neurotoxin-induced PD models, middle cerebral artery occlusion for ischemia, or high-fat diet for metabolic dysfunction) or relevant in vitro neuronal/glial cell lines
